natgillin/translations-raw huggingface dataset:
If Glatfelter increased the price significantly and profitability for wet laid fibre materials for tea and coffee filtration thus possibly increased for Ahlstrom, Ahlstrom could divert capacity or could invest in adding capacity by converting an existing machine or purchasing and converting a second hand machine.
Če bi podjetje Glatfelter znatno povišalo ceno in bi se s tem verjetno povečala donosnost podjetju Ahlstrom za v mokrem pregani papir za filtriranje čajev in kave, bi lahko podjetje Ahlstrom preusmerilo zmogljivosti ali bi lahko investiralo v povečanje zmogljivosti s prilagoditvijo namembnosti obstoječih strojev ali nakupom in prilagoditvijo namembnosti rabljenih strojev.
Ahlstrom has the know-how and technology in order to be able to convert and operate such a machine.
Ahlstrom ima znanje in tehnologijo, da lahko spremeni namembnost takega stroja in ga upravlja.
Ahlstrom also has the distribution and sales network already in place.
Ahlstrom ima tudi že distribucijsko in prodajno mrežo.
Finally, other suppliers of wet laid fibre material with the capability of producing wet laid fibre material for tea and coffee filtration are also constraining Glatfelter.
Poleg tega pa tudi drugi dobavitelji v mokrem preganega papirja, ki lahko proizvajajo v mokrem pregani papir za filtriranje čajev in kave, omejujejo podjetje Glatfelter.
They currently do not all have the ability to produce double layer wet laid fibre materials and also seem to target smaller customers with lower quality standards than most of the bigger customers.
Trenutno nimajo vsi zmožnosti proizvajati dvoslojni v mokrem pregani papir in videti je tudi, da so bolj usmerjeni na manjše kupce, ki imajo nižje standarde kot večina velikih kupcev.
However, when those suppliers have developed their wet laid fibre materials for coffee and tea filtration further they may also target bigger customers.
Vendar ko bodo ti dobavitelji bolj razvili svoje v mokrem pregane papirje za filtriranje čajev in kave, bodo lahko poslovali tudi z večjimi strankami.
Moreover, even without targeting the bigger customers they may be able to increase their sales volume, thereby taking away sales of other producers in tea and coffee filtration, leaving Glatfelter unable to increase its prices or restrict output.
Svoj obseg prodaje pa lahko povečajo tudi brez velikih strank in s tem odvzamejo delež prodaje drugim proizvajalcem kavnih in čajnih filtrov, ter tako onemogočijo, da bi lahko podjetje Glatfelter dvignilo svoje cene ali omejilo proizvodnjo.
The Commission has also found that some competitive pressure is exerted by alternative materials to wet laid fibre materials for tea and coffee filtration (e.g. spun bond and nylon).
Komisija je ugotovila, da nekaj konkurenčnega pritiska izvajajo tudi alternativni materiali v mokrem preganim papirjem za filtriranje čajev in kave (npr. preja in najlon).
While these alternative materials are presently not expected to substitute wet laid fibre material to a significant extent, a portion of customer demand is likely to be redirected towards alternative materials in the future, freeing up additional capacity for wet laid fibre material for tea and coffee filtration and thus to some extent constraining the notifying party’s ability to exercise market power and raise prices.
Medtem ko se zdaj še ne pričakuje, da bi ti alternativni materiali v pomembnem obsegu nadomestili v mokrem pregane papirje, se bo povpraševanje strank v prihodnosti verjetno usmerilo v alternativne materiale in tako še dodatno sprostilo dodatne zmogljivosti za v mokrem pregane papirje za filtriranje čajev in kave ter tako do neke mere omejilo zmožnost priglasitelja, da uveljavlja tržno moč in dviguje cene.
The decision therefore concludes that unilateral effects are unlikely because the party will be constrained in its ability to increase prices by a number of strong competitors and to a certain extent by alternative materials.
Odločba zato ugotavlja, da enostranski učinki niso verjetni, saj bodo stranko v njeni zmogljivosti dvigovanja cen omejili številni močni konkurenti in v določeni meri alternativni materiali.
With regard to co-ordinated effects, the decision also concludes that such effects are unlikely having carefully examined the market structure, the reaction of customers and the reaction of current and potential competitors.
Glede na usklajene učinke Odločba tudi zaključuje, da po natančni obravnavi strukture trga in odzivov strank ter trenutnih in potencialnih konkurentov taki učinki niso verjetni.
The Commission’s investigation indicates that the market segment for battery pasting paper is characterised by low demand with high potential supply from other wet laid fibre producers, a concentrated demand side and that the projected market share of the combined entity would be low.
Preiskava Komisija kaže, da tržni segment za laminirane papirje označuje nizko povpraševanje in visok potencial dobave s strani drugih proizvajalcev v mokrem preganih papirjev, koncentrirano povpraševanje in da bi bil predvideni tržni delež kombiniranega podjetja nizek.
On that basis the Commission considers that this market is unlikely to suffer an anti-competitive impact from the proposed transaction.
Na tej podlagi Komisija meni, da ni verjetno, da bi predlagana transakcija na trgu imela protikonkurenčen učinek.
On 6 December 2006, the 146th Advisory Committee on Concentrations gave a favourable opinion on the draft decision and gave approval to the adoption of the decision.
Svetovalni odbor za koncentracije je 6. decembra 2006 podal pozitivno mnenje o osnutku odločbe in dal odobritev za sprejetje Odločbe.
CONCLUSION
SKLEPNA ODLOČITEV
The decision concludes that the proposed concentration will not significantly impede effective competition in the common market or in a substantial part of it, in particular as a result of the creation or strengthening of a dominant position.
V Odločbi se ugotavlja, da predlagana koncentracija ne ovira bistveno učinkovite konkurence na skupnem trgu ali na njegovem znatnem delu, zlasti kot posledica oblikovanja ali krepitve prevladujočega položaja.
It therefore declares the concentration compatible with the common market and the EEA Agreement, in accordance with Articles 2(2) and Article 8(1) of the Merger Regulation, and Article 57 of the EEA Agreement.
Zato razglaša koncentracijo združljivo s skupnim trgom in Sporazumom EGP, v skladu s členom 2(2) in členom 8(1) Uredbe o združitvah ter členom 57 Sporazuma EGP.
It is therefore concluded that the Commission, by oral procedure has: taken note of the opinion of the Advisory Committee of 6 December 2006; taken note of the final report of the Hearing Officer in this case; and adopted the attached decision in English, which is the authentic language.
Zato se sklene, da Komisija na podlagi ustnega postopka: upošteva Mnenje Svetovalnega odbora z dne 6. decembra 2006; se seznani s končnim poročilom pooblaščenca za zaslišanje v tej zadevi; in sprejme priloženo odločbo v angleškem jeziku, ki je verodostojni jezik.
of 12 June 2007
z dne 12. junija 2007
allowing Member States to extend provisional authorisations granted for the new active substance novaluron
o dovoljenju državam članicam za podaljšanje začasnih registracij, odobrenih za novo aktivno snov novaluron
(notified under document number C(2007) 2454)
(notificirano pod dokumentarno številko C(2007) 2454)
In accordance with Article 6(2) of Directive 91/414/EEC, in March 2001 the United Kingdom received an application from Makhteshim Agan Ltd. for the inclusion of the active substance novaluron in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo marca 2001 prejelo zahtevek od družbe Makhteshim Agan Ltd. za vključitev aktivne snovi novaluron v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2001/861/EC [2] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Odločba Komisije 2001/861/ES [2] je potrdila, da je dokumentacija popolna in da načeloma izpolnjuje zahteve po podatkih in informacijah iz Prilog II in III k navedeni direktivi.
Confirmation of the completeness of the dossier was necessary in order to allow it to be examined in detail and to allow Member States the possibility of granting provisional authorisations, for periods of up to three years, for plant protection products containing the active substance concerned, while complying with the conditions laid down in Article 8(1) of Directive 91/414/EEC and, in particular, the condition relating to the detailed assessment of the active substance and the plant protection product in the light of the requirements laid down by that Directive.
Potrditev popolnosti dokumentacije je bila potrebna zato, da se omogoči podroben pregled snovi in da se državam članicam omogoči, da odobrijo začasne registracije za največ tri leta za fitofarmacevtska sredstva, ki vsebujejo zadevno aktivno snov, ob skladnosti s pogoji iz člena 8(1) Direktive 91/414/EGS in zlasti pogojem v zvezi s podrobno oceno aktivne snovi in fitofarmacevtskega sredstva glede na zahteve, določene z navedeno direktivo.
The rapporteur Member State submitted the draft assessment report to the Commission on 19 September 2005.
Država članica poročevalka je Komisiji 19. septembra 2005 predložila osnutek poročila o oceni.
Following submission of the draft assessment report by the rapporteur Member State, it has been found to be necessary to request further information from the applicant and to have the rapporteur Member State examine that information and submit its assessment.
Po predložitvi osnutka ocene poročila države članice poročevalke je bilo ugotovljeno, da je treba od vlagateljev zahtevati nadaljnje informacije, ki jih država članica poročevalka pregleda, in predloži svojo oceno.
As the evaluation so far has not identified any reason for immediate concern, Member States should be given the possibility of prolonging provisional authorisations granted for plant protection products containing the active substance concerned for a period of 24 months in accordance with the provisions of Article 8 of Directive 91/414/EEC so as to enable the examination of the dossier to continue.
Ker pri ocenjevanju še ni bil ugotovljen nikakršen razlog za neposredno zaskrbljenost, je treba državam članicam v skladu z določbami člena 8 Direktive 91/414/EGS omogočiti podaljšanje začasnih registracij, odobrenih za fitofarmacevtska sredstva, ki vsebujejo zadevno aktivno snov, za 24 mesecev, da se omogoči nadaljevanje pregledovanja dokumentacije.
It is expected that the evaluation and decision-making process with respect to a decision on possible Annex I inclusion for novaluron will have been completed within 24 months.
Pričakuje se, da bo postopek ocenjevanja in odločanja glede odločitve o morebitni vključitvi v Prilogo I za novaluron zaključen v 24 mesecih.
Member States may extend provisional authorisations for plant protection products containing novaluron for a period not exceeding 24 months from the date of adoption of this Decision.
Države članice lahko podaljšajo začasne registracije za fitofarmacevtska sredstva, ki vsebujejo novaluron, za obdobje, ki ni daljše od 24 mesecev, od datuma sprejetja te odločbe.
Done at Brussels, 12 June 2007.
V Bruslju, 12. junija 2007
Directive as last amended by Commission Directive 2007/31/EC (OJ L 140, 1.6.2007, p. 44).
Direktiva, kakor je bila nazadnje spremenjena z Direktivo Komisije 2007/31/ES (UL L 140, 1.6.2007, str. 44).
on a harmonised monitoring of antimicrobial resistance in Salmonella in poultry and pigs
o usklajenem spremljanju odpornosti proti protimikrobnim sredstvom salmonele pri perutnini in prašičih
(notified under document number C(2007) 2421)
(notificirano pod dokumentarno številko C(2007) 2421)
Having regard to Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and zoonotic agents, amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC [1], and in particular Article 7(3) thereof,
ob upoštevanju Direktive 2003/99/ES Evropskega parlamenta in Sveta z dne 17. novembra 2003 o spremljanju zoonoz in povzročiteljev zoonoz, ki spreminja Odločbo Sveta 90/424/EGS in razveljavlja Direktivo Sveta 92/117/EGS [1] in zlasti člena 7(3) Direktive,
Pursuant to Directive 2003/99/EC, Member States shall ensure that monitoring provides comparable data on the occurrence of antimicrobial resistance in zoonotic agents and, in so far as they present a threat to public health, other agents.
V skladu z Direktivo 2003/99/ES države članice zagotovijo, da spremljanje daje primerljive podatke o odpornosti proti protimikrobnim sredstvom povzročiteljev zoonoz in drugih povzročiteljev, v kolikor ti pomenijo nevarnost za javno zdravje.
A FAO/OIE/WHO workshop on scientific assessment on non-human usage of antimicrobials and antimicrobial resistance in 2003 concluded that there is clear evidence of adverse human health consequences due to resistant organisms resulting from non-human usage of antimicrobials: increased frequency of infections, increased frequency of treatment failures (in some cases death) and increased severity of infections, as documented for instance by fluoroquinolone-resistant human Salmonella infections.
Delavnica FAO/OIE/WHO za uporabe protimikrobnih sredstev, drugih kot za ljudi, in protimikrobne odpornosti je leta 2003 sklenila, da obstaja jasen dokaz negativnih posledic odpornih organizmov, povzročenih z uporabo protimikrobnih sredstev, drugih kot za ljudi, na zdravje ljudi: povečana pogostost okužb, povečana pogostost napak pri zdravljenju (v nekaterih primerih smrt) in povečana resnost okužb, kot je na primer dokumentirano s človeškimi okužbami s salmonelo, odpornimi na fluorokinolon.
Evidence shows that the amount and pattern of non-human usage of antimicrobials affect the occurrence of resistant bacteria in animals and food and thereby human exposure to these resistant bacteria (Joint FAO/OIE/WHO Expert Workshop, 2003).
Dokazi kažejo, da količina in vzorec uporabe protimikrobnih sredstev, drugih kot za ljudi, vplivata na pojav odporne bakterije v živalih in hrani, s tem pa na izpostavljenost ljudi tem odpornim bakterijam (Skupna izvedenska delavnica FAO/OIE/WHO, 2003).
However, it should be noted that most of the resistance problems in human medicine are caused by human usage and over usage of antimicrobial agents for therapy and prophylaxis (European Parliament, October 2006).
Vendar pa je treba navesti, da večino problemov odpornosti v humani medicini povzroča človeška uporaba in prevelika uporaba protimikrobnih agensov za terapije in preventivo (Evropski parlament, oktober 2006).
The European Food Safety Authority (EFSA) indicates in its ‘Community Summary Report on Trends and Sources of Zoonoses, Zoonotic agents, Antimicrobial Resistance and Foodborne Outbreaks in the European Union in 2005’ [2] that a relatively high proportion of Campylobacter and Salmonella isolates from animals and food were resistant to antimicrobials commonly used in treatment of human diseases.
Evropska agencija za varnost hrane (EFSA) v svojem „Zbirnem poročilu Skupnosti o trendih in virih zoonoz, njihovih povzročiteljih, protimikrobni odpornosti in izbruhih okužb, ki se prenašajo s hrano, v Evropski uniji v letu 2005“ [2] navaja, da je bil sorazmerno velik delež izolatov Campylobacter in salmonele iz živali in hrane odporen na protimikrobna sredstva, ki se pogosto uporabljajo pri zdravljenju človeških bolezni.
Food-borne infections caused by these resistant bacteria pose a particular risk to humans due to possible treatment failure.
Okužbe, ki se prenašajo s hrano in so posledica odporne bakterije, pomenijo posebno nevarnost zaradi možnega napačnega zdravljenja.
The Scientific Panel on Biological Hazards and of the Scientific Panel an Animal Health and Welfare of the EFSA, adopted an Opinion on ‘Review of the Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial Resistance in the European Union in 2004’ [3] during its meeting on respectively 7 and 8 September 2006.
Na svojih srečanjih 7. oziroma 8. septembra 2006 sta Znanstveni odbor za biološka tveganja in Znanstveni odbor za zdravje in dobro počutje EFSA sprejela Mnenje o „Pregledu zbirnega poročila Skupnosti o trendih in virih zoonoz, njihovih povzročiteljih, protimikrobni odpornosti in izbruhih okužb, ki se prenašajo s hrano, v Evropski uniji v letu 2004“ [3].
With regard to antimicrobial resistance testing, the Opinion indicates the importance to provide detailed information on the Salmonella serovar for each isolate and to harmonise the breakpoints applied for resistance assessment and reporting.
Glede testiranja na protimikrobno odpornost Mnenje navaja pomembnost zagotavljanja podrobnih informacij o Salmonelli serovar za vsak izolat in usklajevanja presečnih vrednosti, uporabljenih za ocenjevanje in poročanje odpornosti.
The Task Force on Zoonoses Data Collection of the EFSA adopted a ‘Report including a proposal for a harmonised monitoring scheme of antimicrobial resistance in Salmonella in fowl (Gallus gallus), turkeys and pigs and Campylobacter jejuni and C. coli in broilers’ [4] on 20 February 2007.
Delovna skupina EFSA o podatkovni zbirki za zoonoze je 20. februarja 2007 sprejela „Poročilo, ki vključuje predlog za shemo usklajenega spremljanja odpornosti proti protimikrobnim sredstvom salmonele pri perutnini (Gallus gallus), puranih in prašičih ter Campylobacter jejuni in Campylobacter coli pri pitovnih piščancih“ [4].
The report makes recommendations on a harmonised monitoring scheme and harmonised methodology for susceptibility testing.
Poročilo priporoča usklajeno shemo spremljanja in usklajeno metodologijo testiranja občutljivosti.
In view of the increasing public health risk posed by antimicrobial resistance and the evidence that use of antibiotics affects this risk, comparable information should be collected from all Member States on the antimicrobial resistance occurrence in zoonotic agents in animals by implementing Article 7 of Directive 2003/99/EC.
Glede na povečano nevarnost za javno zdravje zaradi protimikrobne odpornosti in dokaze, da uporaba antibiotikov vpliva na to nevarnost, morajo vse države članice zbirati primerljive podatke o pojavu protimikrobne odpornosti v povzročiteljih zoonoz pri živalih tako, da izvajajo člen 7 Direktive 2003/99/ES.
This implementation should be based on the proposal of the EFSA Task Force but is without prejudice to further implementation rules in the future.
To izvajanje mora temeljiti na predlogu delovne skupine EFSA, vendar ne posega v nadaljnja izvedbena pravila v prihodnosti.
This Decision lays down detailed rules for monitoring antimicrobial resistance in accordance with Article 7(3) and Annex II(B) of Directive 2003/99/EC to be carried out in the Member States.
Ta odločba določa podrobna pravila za spremljanje protimikrobne odpornosti v skladu s členom 7(3) in Prilogo II(B) Direktive 2003/99/ES, ki jih je treba izvajati v državah članicah.
It shall cover Salmonella spp. in fowl (Gallus gallus), turkeys, and slaughter pigs without prejudice to additional antimicrobial resistance monitoring in accordance with the requirements in Article 7(1) of Directive 2003/99/EC.
Zajema Salmonella spp. pri perutnini (Gallus gallus), puranih in klavnih prašičih, brez poseganja v dodatno spremljanje protimikrobne odpornosti v skladu z zahtevami člena 7(1) Direktive 2003/99/ES.
Collection and analyses of isolates
Zbiranje in analiza izolatov
The collection of isolates of Salmonella spp. referred to in Article 1 and the analysis thereof shall be performed by the competent authority or under its supervision in accordance with the technical specifications set out in the Annex.
Zbiranje izolatov Salmonella spp. iz člena 1 in njihovo analizo opravi pristojni organ ali se opravi pod njegovim nadzorom v skladu s tehničnimi specifikacijami iz Priloge.
Confidentiality of the data
Zaupnost podatkov
National aggregated data and results of the analyses shall be made available publicly in a form that ensures confidentiality.
Nacionalni zbirni podatki in rezultati analiz se dajo na voljo javnosti v obliki, ki zagotavlja zaupnost.
This Decision shall apply from 1 January 2008.
Ta odločba se uporablja od 1. januarja 2008.
Directive amended by Council Directive 2006/104/EC (OJ L 363, 20.12.2006, p. 352).
Direktiva, kakor je bila spremenjena z Direktivo Sveta 2006/104/ES (UL L 363, 20.12.2006, str. 352).
The EFSA Journal (2006), 94.
The EFSA Journal [Bilten EFSA] (2006) 94.
The EFSA Journal (2006), 403, pp. 1 to 62.
The EFSA Journal [Bilten EFSA] (2006) 403, 1–62.
The EFSA Journal (2007) 96, pp. 1 to 46.
The EFSA Journal [Bilten EFSA] (2007) 96, 1–46.
TECHNICAL SPECIFICATIONS REFERRED TO IN ARTICLE 2
TEHNIČNE SPECIFIKACIJE IZ ČLENA 2
Origin of isolates
Poreklo izolatov
Salmonella isolates collected through control and monitoring programmes, set up in accordance with Article 5 of Regulation (EC) No 2160/2003 of the European Parliament and of the Council [1] and/or Commission Decisions 2006/662/EC [2], 2006/668/EC [3], shall be collected for antimicrobial resistance monitoring in accordance with Table 1.Table 1:
Izolati salmonele, zbrani s programi nadzora in spremljanja, vzpostavljenimi v skladu s členom 5 Uredbe (ES) št. 2160/2003 Evropskega parlamenta in Sveta [1] in/ali odločb Komisije 2006/662/ES [2], 2006/668/ES [3], se v skladu z razpredelnico 1 zberejo za spremljanje protimikrobne odpornosti.Razpredelnica 1
Years in which certain zoonotic agents isolated from the indicated animal populations shall be selected for antimicrobial resistance testing
Leta, v katerih se določeni povzročitelji zoonoz, izolirani od navedene populacije živali, izberejo za testiranje na protimikrobno odpornost
All Salmonella serovars
Vse Salmonelle serovar
Slaughter pigs
Klavni prašiči
Not more than one isolate per Salmonella serovar from the same epidemiological unit per year shall be included in the monitoring.
V spremljanje se vključi največ en izolat na Salmonello serovar iz enake epidemiološke enote letno.
The epidemiological unit for laying hens, broilers, and turkeys is the flock.
Epidemiološka enota za kokoši nesnice, pitovne piščance in purane je jata.
For pigs, the epidemiological unit is the holding.
Za prašiče je epidemiološka enota gospodarstvo.
Number of isolates to be tested
Število izolatov za testiranje
The number of Salmonella isolates to be included in the antimicrobial resistance monitoring per Member State per year shall be 170 for each study population (i.e. laying hens, broilers, turkeys and slaughter pigs).
Število izolatov salmonele, ki jih je treba vključiti v spremljanje protimikrobne odpornosti na državo članico letno, je 170 za vsako populacijo v raziskavi (tj. kokoši nesnice, pitovne piščance, purane in klavne prašiče).
In those Member States where, in any given year, a lower number of isolates than the target sample size is available from the monitoring or control programmes, all these isolates shall be included in the antimicrobial resistance monitoring.
V navedenih državah članicah, v katerih je v katerem koli letu za programe spremljanja in nadzora na voljo manj izolatov, kot je ciljna velikost vzorca, se vse te izolate vključi v spremljanje protimikrobne odpornosti.
In those Member States where a higher number of isolates is available all isolates, or a representative random selection equal or larger than the target sample size, shall be included.
V navedenih državah članicah, v katerih je na voljo več izolatov, se vključi vse izolate ali reprezentativno naključno izbrano število, ki je enako ali večje kot ciljna velikost vzorca.
Antimicrobial susceptibility testing
Testiranje protimikrobne občutljivosti
Member States shall test at least the antimicrobials that are specified in Table 2, using the cut-off values given and an appropriate concentration range to determine the susceptibility of Salmonella.
Države članice opravijo teste vsaj za protimikrobna sredstva, ki so določena v razpredelnici 2, pri čemer uporabijo presečne vrednosti in ustrezna območja koncentracije za določitev občutljivosti salmonele.